Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

Aroa Biosurgery

US

Last updated May 24, 2026

Part of Aroa Biosurgery Ltd.

Information

Country
US
Address
—
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
—

Catalogue (146)

Page 3 of 3
DeviceModel / ReferenceRegistriesClassStatus
Endoform Myriad MR05LG0505
FDA UDI
UUnknown
Endoform™ Antimicrobial Restorative Bioscaffold 629313
FDA UDI
UActive
Endoform Antimicrobial Dermal Template 629304
FDA UDI
UActive
Endoform Natural Dermal Template 529311
FDA UDI
UActive
Ovitex® PRS R20353-2022G
FDA UDI
Class IIUnknown
Restella R20343-2022P
FDA UDI
Class IIUnknown
Myriad Matrix™ Soft Tissue Bioscaffold SR05LG1010US
FDA UDI
UActive
Myriad Matrix™ Soft Tissue Bioscaffold SR05LG0505US
FDA UDI
UActive
Myriad Matrix™ Soft Tissue Bioscaffold SR05LG0710US
FDA UDI
UActive
Ovitex® PRS R20343-1622P
FDA UDI
Class IIUnknown
Symphony™ Proliferative Bioscaffold CM03HA006R
FDA UDI
UActive
Myriad Morcells™ PW01NA2000
FDA UDI
UUnknown
Restella R20243-0717P
FDA UDI
Class IIUnknown
Symphony™ Proliferative Bioscaffold CM04HA1010
FDA UDI
UActive
Restella R20143-0416P
FDA UDI
Class IIUnknown
OviTex® IHR F10244-1017I
FDA UDI
Class IIActive
Ovitex® PRS R20253-0815G
FDA UDI
Class IIUnknown
Myriad Matrix™ Soft Tissue Bioscaffold SR05LG1020US
FDA UDI
UActive
Ovitex® PRS R20253-1020G
FDA UDI
Class IIUnknown
Ovitex® PRS R20143-1620P
FDA UDI
Class IIUnknown
Endoform Surface SR03LG1010
FDA UDI
UUnknown
Symphony™ Proliferative Bioscaffold CM03HA006S
FDA UDI
UActive
Ovitex® PRS R20243-1020P
FDA UDI
Class IIUnknown
Restella R20253-0717G
FDA UDI
Class IIUnknown
Symphony™ Proliferative Bioscaffold CM03HA009S
FDA UDI
UUnknown
Endoform Antimicrobial Dermal Template 629311
FDA UDI
UActive
Endoform™ Antimicrobial Restorative Bioscaffold 629315
FDA UDI
UActive
Restella R20353-1622G
FDA UDI
Class IIUnknown
Myriad Matrix™ Soft Tissue Bioscaffold SR03LG1010US
FDA UDI
UActive
Symphony™ Proliferative Bioscaffold CM03HA012R
FDA UDI
UActive
Symphony™ Proliferative Bioscaffold CM03HA035R
FDA UDI
UUnknown
Endoform™ Natural Restorative Bioscaffold 529312
FDA UDI
UActive
Ovitex® PRS R20153-0820G
FDA UDI
Class IIUnknown
Endoform Natural Dermal Template 529314
FDA UDI
UActive
Ovitex® PRS R30353-2025G
FDA UDI
Class IIUnknown
Ovitex® PRS R30343-1622P
FDA UDI
Class IIUnknown
OviTex® IHR F10243-1017I
FDA UDI
Class IIActive
Symphony™ Proliferative Bioscaffold CM04HA0202
FDA UDI
UActive
Endoform Natural Dermal Template 529312
FDA UDI
UActive
Endoform Natural Dermal Template 529313
FDA UDI
UActive
Ovitex® PRS R20243-1122P
FDA UDI
Class IIUnknown
Myriad Matrix™ Soft Tissue Bioscaffold SR03LG2020US
FDA UDI
UActive
Endoform Myriad MR03LG1010
FDA UDI
UUnknown
Ovitex® PRS R30343-2025P
FDA UDI
Class IIUnknown
Endoform Topical Matrix K171231
FDA 510(k)
UActive
Endoform Silver Dermal Template K172318
FDA 510(k)
UActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (21)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

DateRecall No.ClassStatusReason
Apr 6, 2018Z-0417-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0429-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0419-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0422-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0420-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0433-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0415-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0431-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0423-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0421-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0425-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0428-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0432-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0426-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0416-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0434-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0418-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0427-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0435-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0424-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0430-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.